Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant

https://ift.tt/RnGcMUB

Sarclisa^® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with newly diagnosed multiple myeloma not eligible for transplant

from Sanofi - Aventis Groupe https://ift.tt/wvpqhNI
via IFTTT

" May good health envelop you, spurring a quick recovery. .. "

from health care https://ift.tt/782Th3z
via IFTTT https://ift.tt/6JnfAT4

SHARE

Milan Tomic

Hi. I’m Designer of Blog Magic. I’m CEO/Founder of ThemeXpose. I’m Creative Art Director, Web Designer, UI/UX Designer, Interaction Designer, Industrial Designer, Web Developer, Business Enthusiast, StartUp Enthusiast, Speaker, Writer and Photographer. Inspired to make things looks better.

• 
• 
• 
• 
•